These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415 [TBL] [Abstract][Full Text] [Related]
5. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244 [TBL] [Abstract][Full Text] [Related]
6. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283 [TBL] [Abstract][Full Text] [Related]
7. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112 [TBL] [Abstract][Full Text] [Related]
8. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors. Yuan B; Oechsli MN; Hendler FJ Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609 [TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Nishida N; Fukuda Y; Komeda T; Kita R; Sando T; Furukawa M; Amenomori M; Shibagaki I; Nakao K; Ikenaga M Cancer Res; 1994 Jun; 54(12):3107-10. PubMed ID: 8205525 [TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318 [TBL] [Abstract][Full Text] [Related]
11. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Freier K; Sticht C; Hofele C; Flechtenmacher C; Stange D; Puccio L; Toedt G; Radlwimmer B; Lichter P; Joos S Genes Chromosomes Cancer; 2006 Feb; 45(2):118-25. PubMed ID: 16235239 [TBL] [Abstract][Full Text] [Related]
12. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462 [TBL] [Abstract][Full Text] [Related]
13. Amplification and expression of the human cyclin D gene in esophageal cancer. Jiang W; Kahn SM; Tomita N; Zhang YJ; Lu SH; Weinstein IB Cancer Res; 1992 May; 52(10):2980-3. PubMed ID: 1533816 [TBL] [Abstract][Full Text] [Related]
14. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334 [TBL] [Abstract][Full Text] [Related]
15. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340 [TBL] [Abstract][Full Text] [Related]
18. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641 [TBL] [Abstract][Full Text] [Related]
19. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801 [TBL] [Abstract][Full Text] [Related]
20. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]